Jayaprakash Madhavan

Author

Regional Cancer Center, Thiruvananthapuram

Also Known As

J Madhavan, J. Madhavan, J. P. Madhavan, J.P. Madhavan, Jayaprakash Madhavan, K Sujathan

Publications

2.4K

Citations

H-Index

Concepts

All Affiliations

Regional Cancer Center, Thiruvananthapuram National Centre for Earth Science Studies Jaslok Hospital Tata Memorial Hospital Jehangir Hospital

About

Jayaprakash Madhavan is an author at Regional Cancer Center, Thiruvananthapuram specializing in medicine, pathology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	18	1.8K
2	Health Sciences	8	8	1.4K
3	Engineering	2	2	47
4	Public Health	2	2	85
5	Cell Biology	1	1	21

Jayaprakash Madhavan

Publications

2.3K

Citations

H-Index

Page 1

	Year	Citations
Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer: a randomised, double-blind, phase 3 study Tudor–Eliade Ciuleanu, Thomas Brodowicz, Christoph Zielinski, The Lancet Non-small-cell Lung CancerMedicineCancer ManagementClinical TrialsCancer Treatment	2009	1.1K
Diagnostic Value of 68Ga PSMA-11 PET/CT Imaging of Brain Tumors—Preliminary Analysis Arun Sasikumar, Ajith Joy, M. R. A. Pillai, Clinical Nuclear Medicine	2016	130
Possible risk modification by CYP1A1, GSTM1 and GSTT1 gene polymorphisms in lung cancer susceptibility in a South Indian population Leelakumari Sreeja, Vani Syamala, Sreedharan Hariharan, Journal of Human Genetics South Indian PopulationOncologyPossible Risk ModificationMedicineGenetics	2005	93
Oral cancer detection using diffuse reflectance spectral ratio R540∕R575 of oxygenated hemoglobin bands Narayanan Subhash, J. R. Mallia, Shiny Sara Thomas, Journal of Biomedical Optics Oral Cancer DetectionPathologyDiffuse Reflectance IntensityLight Scattering SpectroscopySpectrochemical Analysis	2006	88
Randomized, Double-Blind, Placebo-Controlled Phase II Study of Single-Agent Oral Talactoferrin in Patients With Locally Advanced or Metastatic Non–Small-Cell Lung Cancer That Progressed After Chemotherapy Purvish M. Parikh, Ashok K. Vaid, Suresh H. Advani, Journal of Clinical Oncology	2011	75
Prognostic importance of DNA repair gene polymorphisms of XRCC1 Arg399Gln and XPD Lys751Gln in lung cancer patients from India Leelakumari Sreeja, Volga S. Syamala, Vani Syamala, Journal of Cancer Research and Clinical Oncology Xrcc1 Arg399glnOncologyMedicineGeneticsHuman Polymorphism	2007	74
Conservative surgery and radiotherapy in the treatment of spinal cord astrocytoma R. Jyothirmayi, Jayaprakash Madhavan, Madhavan Krishnan Nair, Journal of Neuro-Oncology	1997	73
Quality of life in patients with advanced non-small-cell lung cancer given maintenance treatment with pemetrexed versus placebo (H3E-MC-JMEN): results from a randomised, double-blind, phase 3 study Chandra P. Belani, Thomas Brodowicz, Tudor–Eliade Ciuleanu, The Lancet Oncology OncologyHealth SciencesMaintenance TreatmentCancer ManagementClinical Trials	2012	68
A Randomized, Double-Blind, Placebo-Controlled, Phase II Study of Oral Talactoferrin in Combination with Carboplatin and Paclitaxel in Previously Untreated Locally Advanced or Metastatic Non-small Cell Lung Cancer Raghunadharao Digumarti, Yenyun Wang, G. Raman, Journal of Thoracic Oncology OncologyMedicinePhase Ii StudyBronchial NeoplasmPharmacotherapy	2011	67
Laser‐induced autofluorescence spectral ratio reference standard for early discrimination of oral cancer Rupananda J. Mallia, Shiny Sara Thomas, Anitha Mathews, Cancer	2008	60

Page 1